The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after the implant, the patient experienced infected mesh, open wound, hernia recurrence, mesh migration, scarring, chronic draining abdominal wound, sinus tract, wadded mesh, necrosis, granulomatous changes, and inflammation.
Post-operative patient treatment included wound vac, mesh removal, partial explant of omentum, excision of previous scar and wound, debridement of abdominal wall, removal of sutures, hernia repair with sutures, wound debrided, skin closed loosely with intermittent telfa wicks, and revision surgery.
|